KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,391 | +9862.5% | 1,708 | +42600.0% | 0.00% | – |
| Q4 2022 | $24 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $3,678,000 | -5.2% | 307,800 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $3,881,000 | +12.0% | 307,800 | 0.0% | 0.01% | +37.5% |
| Q1 2022 | $3,466,000 | -36.5% | 307,800 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $5,454,000 | -23.0% | 307,800 | 0.0% | 0.01% | -23.1% |
| Q3 2021 | $7,086,000 | -1.1% | 307,800 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $7,166,000 | -25.3% | 307,800 | 0.0% | 0.01% | -31.6% |
| Q1 2021 | $9,591,000 | -3.6% | 307,800 | +23.1% | 0.02% | -5.0% |
| Q4 2020 | $9,945,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |